Institutional Ownership
C4 Therapeutics Inc
CUSIP 12529R107COM STKCCCCQ1 2026
Institutional Holders
119
13F filers
Shares Held
80.06M
Aggregate institutional
Institutional Value
$204.08M
Q1 2026
Net New Holders
+20
31 new · 11 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions31
Increased41
Decreased29
Sold out11
Institutional Holders
119 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | 9.07M | $23.86M | +90.7K | Added |
| 2 | Ra Capital Management, L.P. | 8.00M | $21.04M | 0 | Held |
| 3 | Bain Capital Life Sciences Investors, LLC | 7.17M | $18.86M | 0 | Held |
| 4 | Lynx1 Capital Management LP | 7.00M | $18.41M | −99.2K | Reduced |
| 5 | Soleus Capital Management, L.P. | 3.80M | $10.00M | 0 | Held |
| 6 | Two Sigma Investments, LP | 3.04M | $7.98M | +1.53M | Added |
| 7 | Wasatch Advisors LP | 2.96M | $7.79M | −1.38M | Reduced |
| 8 | Jpmorgan Chase & Co | 3.22M | $7.57M | +3.22M | Added |
| 9 | Citadel Advisors LLC | 2.51M | $6.60M | +2.06M | Added |
| 10 | Renaissance Technologies LLC | 2.46M | $6.47M | +859.2K | Added |
109 more institutional holders on Premium
See every fund holding C4 Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders